英文名稱 Anti-CD45RO

中文名稱 CD45RO抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

交叉反應 Human, Mouse, Rat

產(chǎn)品類型 一抗

研究領域 細胞生物 神經(jīng)生物學 干細胞 細胞膜受體 細胞表面分子 糖蛋白 細胞類型標志物 自然殺傷細胞 淋巴細胞t-淋巴細胞 b-淋巴細胞

蛋白分子量 predicted molecular weight: 180kDa

性 狀 Lyophilized or Liquid

免 疫 原 Cultured T cells from an IL-2-dependent T-cell line(CA1) prepared from human peripheral blood activated with influenza virus.

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 B220; CD 45; CD45; cd45 antigen; ec3.1.3.48;CD45R; GP180; GP180; GP 180; L CA; LCA; L-CA; Leukocyte common antigen; LY5;Protein tyrosine phosphatase receptor type C; Protein tyrosine phosphatasereceptor type c polypeptide; protein tyrosine phosphatase, receptor type, C;Receptor-type tyrosine-protein phosphatase C; PTPRC; PTPRC_HUMAN; SCID due toPTPRC deficiency; T200; T200 glycoprotein; T200 leukocyte common antigen; Humanhomolog of severe combined immunodeficiency due to PTPRC deficiency.